Our Active Projects and Spinouts

Protein to Protein Interaction Drug - Fission Bio

Dr. Luis Rios, PhD
Co-Founder & Principal Investigator

Fission Bio is developing a protein-protein interaction inhibitor drug that cuts the link between chronic inflammation and mitochondrial dysfunction to treat multiple age-related and neurodegenerative diseases to extend human lifespan.

Allocated
$200k

Enhancing Protein Translation to Combat Neurodegeneration - 
Project Transfidelity

Dr. Dimitri Scherbakov
University of Zurich

Project Transfidelity aims to enhance the accuracy of protein synthesis to prevent the misfolding and aggregation associated with neurodegenerative diseases like Alzheimer's.

Allocated
$425k+

Combating Memory Loss and Cognitive Decline - Percepta®

Mark Melnykowycz
CerebrumDAO Product Lead

Percepta® is a patent-protected brain health natural dietary supplement (active ingredients, PTI-00703® Cat’s claw and MemorTea® - a specific oolong tea extract).

Allocated
$500k+

Treatments for Alzheimer's and Inflammatory Skin Conditions - 
AT-001

Dr. Hakon Hakonarson MD, PhD
Co-Founder & Chief Medical Advisor

Arctic Therapeutics focuses on creating innovative treatments for neurodegenerative and inflammatory skin diseases. Their lead candidates: AT-001, targets dementia and Alzheimer's, and AT-004, aims to treat inflammatory skin conditions like acne vulgaris.

Allocated
€75k

Are you driving the next big breakthrough in neuroscience?

CerebrumDAO provides the financial support, incubation and a collaborative network dedicated to advancing brain science.

Product
Product
Spinout
Spinout
Equity
Equity
IP-Licence
IP-Licence
IP-Token
IP-Token